Læknaneminn - 01.04.1997, Síða 90

The drug-AIDS
hypothesis:í
Peter Duesberg and David Rasnick
1. Richard Feynman on science......................................................................... 89
2. Why HIV-AIDS science cannot succeed................................................................ 90
2.1. The American/European AIDS epidemic....................................................... 90
2.2. The war on AIDS............................................................................. 90
2.3. AIDS facts incompatible with the HIV-AIDS hypothesis...................................... 91
2.4. Conclusions................................................................................. 92
3. The American/European drug epidemic.................................................................. 92
3.1. Chronology of the drug epidemic in America.................................................. 92
3.2. Chronology of the drug epidemic in Europe................................................... 94
3.3. Epidemiology and age distribution of recreational drugs..................................... 95
3.4. Drug diseases............................................................................... 98
3.5. Conclusions................................................................................ 102
4. The epidemic of AZT and other anti-HIV/AIDS medications............................................ 103
4.1. DNA terminators licensed as a cure........................................................ 103
4.2. Epidemiology of AZT and supplemental anti-HIV/AIDS medications............................ 104
4.3. Diseases caused by AZT and other anti-HIV medicines....................................... 106
4.4. Conclusions................................................................................ 109
5. Drug-AIDS hypothesis................................................................................ 109
6. Predictions are proving the drug-hypothesis........................................................ 111
6.1. American and European AIDS restricted to recreational drugs and AZT....................... 111
6.2. Nine out of ten American/European AIDS patients are males................................. 112
6.3. AIDS and deaths from recreational drugs have the same age distribution.................... 112
6.4. Pediatric AIDS caused by maternal drug addiction.......................................... 112
6.5. WhyAIDSnow?................................................................................ 112
6.6. Risk group-specific AIDS diseases.......................................................... 112
6.7. Not all drug users develop AIDS............................................................ 114
6.8. Non-correlations between HIV and AIDS...................................................... 114
6.9. Discontinuation of drug use either stabilizes or cures AIDS............................... 119
7. How the HIV/AIDS orthodoxy divorces drugs from AIDS................................................ 121
7.1. Disregarding drugs......................................................................... 121
7.2. Misrepresentation of facts, example 1...................................................... 122
7.3. Misrepresentation of facts, example 2...................................................... 122
7.4. Different standards of verification for HIV and drugs...................................... 123
7.5. Omission of facts and controls............................................................. 123
7.6. Confounding “confounding viariables”....................................................... 125
7.7. Grouping drug-using with non-drug using HlV-positives...................................... 125
7.8. Hiding evidence that AZT accelerates death, eleven examples................................ 126
7.9. Conclusions................................................................................ 127
8. A possible solution at last......................................................................... 128
Acknowledgements........................................................................................ 129
References.............................................................................................. 129
LÆKNANEMINN
88
1. tbl. 1997, 50. árg.